A Phase I Study of Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
Phase of Trial: Phase I
Latest Information Update: 07 Dec 2019
Price : $35 *
At a glance
- Drugs LMP 744 (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions
- 18 Jun 2019 Planned number of patients changed from 46 to 50.
- 18 Jun 2019 Status changed from suspended to recruiting.
- 31 Dec 2018 Status changed from recruiting to suspended as Sponsor halted accrual due to low drug supply.